FGF19 and hepatocellular carcinoma: Specifically, in the context of HCC, FGF19 has been shown to interact with the Wnt/β-catenin pathway, further promoting tumor progression through cross-talk mechanisms that enhance the oncogenic potential of both signaling networks.